Exelixis has a total of 3188 patents globally, out of which 1180 have been granted. Of these 3188 patents, more than 40% patents are active. The USA is where Exelixis has filed the maximum number of patents, followed by Australia and Japan. Parallelly, the USA seems to be the main focused R&D center of Exelixis.
Exelixis was founded in the year 1994. The firm is a genomics-based drug discovery company and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for cancer.
Do read about some of the most popular patents of Exelixis which have been covered by us in this article and also you can find Exelixis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Exelixis patent portfolio.
How many patents does Exelixis have?
Exelixis has a total of 3188 patents globally. These patents belong to 443 unique patent families. Out of 3188 patents, 1283 patents are active.
How Many Patents did Exelixis File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Exelixis Applications Filed||Exelixis Patents Granted|
How many Exelixis patents are Alive/Dead?
How Many Patents did Exelixis File in Different Countries?
Countries in which Exelixis Filed Patents
|United States Of America||407|
|Hong Kong (S.A.R.)||125|
Where are Research Centres of Exelixis Patents Located?
10 Best Exelixis Patents
US6511824B1 is the most popular patent in the Exelixis portfolio. It has received 470 citations so far from companies like Diversa Corporation, Verenium Corporation, and Novozymes.
Below is the list of 10 most cited patents of Exelixis:
|Publication Number||Citation Count|
What are Exelixis key innovation segments?
What Technologies are Covered by Exelixis?
The chart below distributes patents filed by Exelixis